These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5738756)

  • 1. [Effects of the tolbutamide test on plasmatic concentration of NEFA in the climacteric].
    Quinto P; Orlandi C
    Minerva Ginecol; 1968 Apr; 20(8):678-87. PubMed ID: 5738756
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the plasmatic concentration of non-esterified fatty acids during the intravenous tolbutamide test in the aged].
    Locatelli GR; Piotti LE
    G Gerontol; 1966 Oct; 14(10):961-8. PubMed ID: 5993793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of plasma NEFA in functional tests of carbohydrate metabolism].
    De Jaco M; Morisi E; Pantano E; Santori L
    Quad Sclavo Diagn; 1979 Jun; 15(2):264-74. PubMed ID: 554163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levels of basal insulinemia and changes of the plasmatic concentration of nonesterified fatty acids (NEFA) and of blood sugar after administration of tolbutamide in obese children].
    Iafusco F; Pierantoni G; Stoppoloni G; Pacelli V
    Pediatria (Napoli); 1967; 75(5):780-8. PubMed ID: 5603123
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in carbohydrate metabolism, plasmatic NEFA and immunoreactive insulin in hepatic cirrhosis].
    Gragnoli G; Pupillo A; Montagnani M; Bayeli PF
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1373-90. PubMed ID: 5759915
    [No Abstract]   [Full Text] [Related]  

  • 6. [Obesity and diabetes. II. Tolbutamide intravenous test in obese patients].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1970 May; 31(2):88-99. PubMed ID: 5470191
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
    Kirti S; Dutta PK; Vaishnava H; Singh RB
    J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbohydrate and fat metabolism in patients with pheochromocytoma.
    Spergel G; Bleicher SJ; Ertel NH
    N Engl J Med; 1968 Apr; 278(15):803-9. PubMed ID: 5642499
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipacidemia and glycemia variations during intravenous tolbutamide test of 126 normal and diabetic persons].
    Deuil R; Deloux G; Duval JM; Davy J; Guinard UJ; Letailleur M
    Diabete; 1968; 16(1):45-53. PubMed ID: 5743942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration].
    Fedeli S; Maglia A
    Arch Sci Med (Torino); 1977; 134(1):33-8. PubMed ID: 860916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive steroids and carbohydrate metabolism.
    Kulkarni HJ; Gaitonde BB
    Indian J Physiol Pharmacol; 1972 Jan; 16(1):23-9. PubMed ID: 5025961
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia.
    Kleinknecht D; Laudat MH; Strauch G; Jungers P; Laudat P
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):27-37. PubMed ID: 5041347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipid-carbohydrate metabolism during operations in patients with diabetes mellitus].
    Davtian NK; Markov IN
    Khirurgiia (Mosk); 1970 Jan; 46(1):109-14. PubMed ID: 5437188
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of 3,5-dimethylisoxazol short-term administration on the carbohydrate metabolism in elderly diabetics with secondary failure of sulfonylurea treatment].
    Geyer G; Sokopp B
    Wien Klin Wochenschr; 1969 Oct; 81(40):701-5. PubMed ID: 5344305
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver disease, insulin antagonism and diabetes mellitus.
    Creutzfeldt W; Frerichs H; Kneer P
    Horm Metab Res; 1974; Suppl 4():135-42. PubMed ID: 4423508
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of the plasmatic STH level in obese subjects following endovenous administration of tolbutamide].
    Carducci Artenisio A; Albanese MC; Allegra V; Alibrando S; Corsi V
    Boll Soc Ital Biol Sper; 1972 May; 48(9):209-12. PubMed ID: 5070090
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of physical exercise on the glyco-lipid effect in normal and diabetic subjects].
    Ferlito S; Di Mauro C; Costa A; Branca S; Raudino M
    G Clin Med; 1980 Oct; 61(10):728-39. PubMed ID: 7016646
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucose tolerance and insulin sensitivity in obesity].
    Balestreri R; Pompei A
    Arch Maragliano Patol Clin; 1966; 22(4):439-51. PubMed ID: 6014634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
    Ulrich E; Frank I; Kujat G; Müller G; Seige K
    Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in serum glucose and free fatty acids after administration of tolbutamide to obese women.
    Harell A; Oberman Z; Herzberg M; Laurin L
    Isr J Med Sci; 1970; 6(2):304-8. PubMed ID: 5506243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.